Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression
NCT01998061
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
EGFR tyrosine kinase inhibitor
DRUG:
EGFR tyrosine kinase inhibitor with chemotherapy
Sponsor
Zhejiang University